tirzepatide and kidney disease Renal effects of GLP-1 receptor agonists in individuals with type 2 diabetes: seeds of a promising future | Endocrine Tirzepatide (Zepbound) showed improved kidney

The cutting phase is where semaglutide enters the picture: Appetite control: As body fat drops below 12% to 15%, hunger signals intensify dramatically

While the medication itself is not known to directly harm the liver, any medication processed by the liver requires careful monitoring in people with liver issues

Leena to weigh in

Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder

GLP-1 medications were originally developed to manage blood sugar in type 2 diabetes, but clinical research has revealed they may also influence cholesterol and triglyceride levels

A patient, Sarah, experienced significant nausea during her first few weeks on Ozempic